Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news


How pharma will be disrupted

Posted 18 February 2021 AM

Major disruptions that will forever change the way pharma operates are already here or on the doorstep, a new report warns, with the way companies handle the changes determining their "licence to operate" in coming years.

While 2020 pushed pharma to its limits, the profound changes triggered by the COVID-19 crisis will outlast the pandemic and new rules will govern the way the industry operates, according to a comprehensive report by McKinsey & Co.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Approvals Action
Pfizer vs Humira
Adds to a growing list of adalimumab biosims
Top of the Hill
How not to reform the PBAC
In the face of deep change, is piecemeal enough?
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas